Compounded semaglutide pricing in 2026 ranges from roughly $130/month to $300/month depending on the provider, dose level, and plan structure. That spread is wide enough that choosing the wrong provider could cost you $1,500+ per year more than necessary for the same active ingredient.
We’ve verified pricing from the telehealth providers we track, focusing on the numbers that actually matter: all-in monthly cost at starter and maintenance doses, including any consultation fees, shipping, or dose-escalation surcharges. “Starting at” prices are often misleading because they reflect the lowest dose and first-month promotions—your real cost at a therapeutic maintenance dose (typically 1.0–2.4mg for semaglutide) is usually higher.
Provider Comparison: Verified Pricing as of May 2026
The providers below are listed in order of approximate value, balancing monthly cost against plan structure and dose-escalation behavior. All offer compounded semaglutide via licensed telehealth with home delivery.
Flat-rate pricing at all dose levels makes Oak a strong value pick, particularly for patients who expect to titrate to maintenance doses. No surprise cost jumps at 1.0mg or above.
Check EligibilityPaid linkStrong first-month discount makes Embody accessible for people wanting to try compounded semaglutide before committing to a higher monthly rate. Injectable format only.
Compare current GLP-1 options →Paid linkSimple, predictable pricing with no long-term commitment required. The $179 flat rate stays the same regardless of dose, which is a genuine advantage over providers that charge more at higher doses.
Check EligibilityPaid linkLegitScript certification adds a layer of third-party verification. Offers both semaglutide and tirzepatide with competitive flat-rate pricing.
Compare current GLP-1 options →Paid linkExplore the program’s treatment pathways and ask which medication type, pharmacy, enrollment requirements and recurring charges apply to your location.
Explore GobyMeds ↗Eligibility and prices must be verified directly. Compounded GLP-1 products are not FDA-approved.Eden acquired their compounding pharmacy (Contigo) in 2025, giving them vertical control over formulation and fulfillment. Higher monthly cost but stronger supply chain integration.
Compare current GLP-1 options →Paid linkSHED offers the widest format variety (injections, sublingual, lozenges) and a rare weight-loss guarantee. However, pricing jumps significantly at higher doses—budget for ~$399/mo if you expect to titrate above 5mg.
Compare current GLP-1 options →Paid linkBrand-Name Alternative: Sesame Care
Sesame connects patients with FDA-approved brand-name GLP-1 medications—not compounded versions. A good fit if you want the regulatory certainty of FDA-approved products or if your insurance covers them. Pricing depends on insurance status and manufacturer programs.
Get StartedPaid linkQuick Comparison Table
| Provider | Sema Starting | At Maintenance | Tirz Available? | Flat Rate? |
|---|---|---|---|---|
| Oak Longevity | $130/mo | $130/mo | Yes ($199/mo) | ✓ Yes |
| Yucca Health | $146/mo | $146/mo | Yes ($258/mo) | ✓ 6-mo plan |
| Embody | $149 (first) | $299/mo | No | ✗ Steps up |
| Gala GLP-1 | $179/mo | $179/mo | No | ✓ Yes |
| BB Health+ | $179/mo | $179/mo | Yes ($209/mo) | ✓ Yes |
| Care Bare Rx | ~$199/mo | ~$199/mo | Verify | Verify |
| Eden Health | $239/mo | $239/mo | Verify | ✓ Yes |
| SHED | $297/mo | ~$399/mo | Yes | ✗ Escalates |
Pricing is approximate and reflects publicly available data as of May 2026. Verify directly with each provider before enrolling, as promotions and plan structures change.
How to Choose: What Matters Beyond Price
The cheapest provider is not always the best value. Here are the factors worth weighing alongside monthly cost:
Dose-Escalation Pricing
Ask specifically: “What will I pay at 1.7mg or 2.4mg semaglutide?” Flat-rate providers like Oak, Gala, and BB Health+ charge the same regardless of dose. Others like SHED and Embody charge more at higher doses. Over a 12-month treatment, the difference can be $1,200+.
Pharmacy Type: 503A vs 503B
503B outsourcing facilities operate under FDA oversight with cGMP requirements. 503A pharmacies compound patient-specific prescriptions under state pharmacy board oversight. Both are legal, but 503B facilities generally have more rigorous quality controls. Note that the FDA’s proposed 503B bulks list removal (April 2026) could affect 503B sourcing for some providers.
What’s Included
Some providers bundle everything (consultation, medication, shipping) into one price. Others charge separately for telehealth visits, lab work, or shipping. A $149/month provider that charges $75 per consultation every 3 months is actually $174/month.
Cancellation Policy
Month-to-month plans offer flexibility. Multi-month prepaid plans offer lower prices but lock you in. Make sure you understand the refund policy before paying upfront for 3–6 months.
See the Full Provider Comparison
Compare all providers side-by-side with safety ratings, pharmacy certifications, and format options.
Compare All Providers →Brand-Name Pricing Context
For context, here’s what FDA-approved brand-name alternatives cost without insurance as of May 2026:
- Wegovy (injectable): ~$1,349/month retail. Manufacturer savings programs may reduce this for eligible patients.
- Wegovy (oral tablets): $149/month for 1.5mg and 4mg doses through Novo Nordisk’s self-pay program (promotional pricing through August 2026, then $199/month for 4mg).
- Ozempic: ~$936–$1,000/month retail (indicated for type 2 diabetes, not weight management).
- Zepbound (tirzepatide): ~$1,086/month retail. LillyDirect self-pay vials: $349–$599 per 4-week supply depending on dose.
Compounded semaglutide at $130–$299/month is substantially cheaper than brand-name alternatives, which is the primary reason it remains popular despite the regulatory uncertainty. The trade-off is that compounded versions are not FDA-approved and have not undergone the same safety and efficacy review as brand-name products.